Polatuzumab Vedotin-piiq
Ibrutinib Plus Bendamustine and Rituximab
Leukemia & Lymphoma Society
National Cancer Institute: Lymphoma—Patient Version
COVID-19 and Aggressive Lymphoma: Frequently Asked Questions Answered by ASH
JNCCN: How to Manage Cancer Care During COVID-19 Pandemic